Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital, recently shared a post on X:
“ASCO Breakthrough ASCOBT24 is in 2 days.
Date: August 8-10, 2024.
Program chair: Melvin LK Chua.
Reasons to Join:
- Japan, Yokohama.
- AI applications.
- Precision oncology.
- Robotics.
- Novel Immunotherapy.”
Additional information.
Source: Hidehito Horinouchi/X